{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-001767","form_type":"8-K","ticker":"GKOS","cik":"0001192448","company_name":"GLAUKOS Corp","filed_at":"2023-02-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.077177+00:00","generated_at":"2026-06-19T04:15:00.903650+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Glaukos Q4 net sales $71.2M, down 3% YoY; full-year net loss $99.2M; guides 2023 sales $290-295M","bullets":["Q4 net sales $71.2M (-3% YoY); glaucoma $52.9M, corneal health $18.3M.","Q4 GAAP net loss $31.5M ($0.66/sh); non-GAAP net loss $25.1M ($0.53/sh).","Full-year 2022 net sales $282.9M (-4% YoY); net loss $99.2M ($2.09/sh).","2023 net sales guidance $290M-$295M; cash & equivalents $360M.","R&D expenses rose 34% in Q4 to $35.8M; SG&A up 9% to $51.9M."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-001767","json":"https://secwatch.observer/filing/0001558370-23-001767.json","markdown":"https://secwatch.observer/filing/0001558370-23-001767.md","text":"https://secwatch.observer/filing/0001558370-23-001767.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/0001558370-23-001767-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/gkos-20230222x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T04:15:00.903650+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"141261f204bebfb9a2dc2371baf97fb1329628eb","claim":"GLAUKOS Corp reported fiscal year 2023 results: revenue $290 million to $295 million. Guidance initiated.","evidence_excerpt":"The company expects 2023 net sales to be in the range of $290 million to $295 million based on the latest foreign currency exchange rates.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/0001558370-23-001767-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023"},{"label":"Revenue","value":"$290 million to $295 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"4607d3eadd95523f2bd25c3a629f1cb348147133","claim":"GLAUKOS Corp reported fourth quarter ended December 31, 2022 results: revenue $71.2 million, net income $31.5 million, EPS ($0.66) per diluted share.","evidence_excerpt":"Net sales in the fourth quarter of 2022 of $71.2 million declined 3% on a reported basis, or were flat on a constant currency basis, compared to $73.2 million in the same period in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/0001558370-23-001767-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$71.2 million"},{"label":"Net income","value":"$31.5 million"},{"label":"EPS","value":"($0.66) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"851e57739457af6ad7c2c05cdb6b9c0e3d4069d7","claim":"GLAUKOS Corp reported fiscal year ended December 31, 2022 results: revenue $282.9 million, net income $99.2 million, EPS ($2.09) per diluted share.","evidence_excerpt":"Net sales in 2022 of $282.9 million declined 4% on a reported basis, or 2% on a constant currency basis, compared to $294.0 million in 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1192448/000155837023001767/0001558370-23-001767-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$282.9 million"},{"label":"Net income","value":"$99.2 million"},{"label":"EPS","value":"($2.09) per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}